Trial Profile
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2019
Price :
$35
*
At a glance
- Drugs Topiramate (Primary) ; Topiramate (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 19 Jul 2019 Status changed from discontinued to withdrawn prior to enrolment.
- 09 Oct 2018 Status changed from recruiting to discontinued.
- 15 Sep 2017 New trial record